Showing 1–2 of 2 results for author: Echeverry-Rendón, M
-
A strategy to tailor the mechanical and degradation properties of PCL-PEG-PCL based copolymers for biomedical application
Authors:
Yu-Yao Liu,
Juan Pedro Fernández Blázquez,
Guang-Zhong Yin,
De-Yi Wang,
Javier Llorca,
Monica Echeverry-Rendón
Abstract:
Biodegradable and biocompatible 3D printable biomaterials with tunable mechanical properties and degradation rate adapted to target tissues were urgently required to manufacture scaffolds for tissue regeneration. Herein, a strategy based on a series of copolymers are proposed where the mechanical and degradation properties can be optimized regarding the specific biological application. With this p…
▽ More
Biodegradable and biocompatible 3D printable biomaterials with tunable mechanical properties and degradation rate adapted to target tissues were urgently required to manufacture scaffolds for tissue regeneration. Herein, a strategy based on a series of copolymers are proposed where the mechanical and degradation properties can be optimized regarding the specific biological application. With this purpose, poly($ε$-caprolactone)-poly(ethylene glycol)-poly($ε$-caprolactone) (PCL-PEG-PCL, PCEC) triblock co-polymers with high molecular weight were synthesized by using PEG with a wide range of molecular weight (from 0.6 kg/mol to 35 kg/mol) as macroinitiators. PCEC copolymers exhibited tunable mechanical properties with an elastic modulus in the range 338-705 MPa and a degradation rate from 60% mass loss after 8 h to 70% mass loss after 23 days in accelerated tests, as well as excellent cytocompatibility and cell attachment after culture with mouse fibroblast L929 cells. The mechanisms responsible for these properties were ascertained by means of different techniques to ascertain the structure-property relationship in PCEC copolymers. Furthermore, it was shown that it is possible to manufacture PCEC scaffolds by 3D printing with excellent dimensional accuracy and controlled microporosity. This study provides a promising strategy to design, select, and fabricate copolymers with tunable mechanical properties and degradation rate for tissue engineering applications.
△ Less
Submitted 29 August, 2023;
originally announced August 2023.
-
Strength, corrosion resistance and cellular response of interfaces in bioresorbable poly-lactic acid/Mg fiber composites for orthopedic applications
Authors:
Wahaaj Ali,
Mónica Echeverry-Rendón,
Alexander Kopp,
Carlos González,
Javier LLorca
Abstract:
The shear strength and the corrosion resistance of the fiber/matrix interface after immersion in simulated body fluid was studied in poly-lactic acid/Mg fiber composites. The shear strength of the interface was measured by means of push-out tests in thin slices of the composite perpendicular to the fibers. It was found that the interface strength dropped from 15.2 \pm 1.4 MPa to 7.8 \pm 3.7 MPa af…
▽ More
The shear strength and the corrosion resistance of the fiber/matrix interface after immersion in simulated body fluid was studied in poly-lactic acid/Mg fiber composites. The shear strength of the interface was measured by means of push-out tests in thin slices of the composite perpendicular to the fibers. It was found that the interface strength dropped from 15.2 \pm 1.4 MPa to 7.8 \pm 3.7 MPa after the composite was immersed in simulated body fluid for 148 hours. The reduction of the interface strength was associated to the fast corrosion of the fibers as water diffused to the interface through the polymer. The expansion of the fibers due to the formation of corrosion products was enough to promote radial cracks in the polymer matrix which facilitate the ingress of water and the development of corrosion pitting in the fibers. Moreover, cell culture testing on the material showed that early degradation of the Mg fibers affected the proliferation of pre-osteoblasts near the Mg fibers due to the local changes in the environment produced by the fiber corrosion. Thus, surface modification of Mg fibers to delay degradation seems to be a critical point for further development of Mg/PLA composites for biomedical applications.
△ Less
Submitted 12 August, 2021;
originally announced August 2021.
